Filing Flows › Comparisons › TNXP vs AYTU
Tonix Pharmaceuticals Holding vs Aytu Biopharma: TNXP and AYTU compared
Tonix Pharmaceuticals Holding is the larger company: $17.2M of revenue in its latest quarter (Q3 2026) against $16.1M for Aytu Biopharma (Q4 FY26). Tonix Pharmaceuticals Holding is growing faster (+424% against +6% a year earlier). Aytu Biopharma is more profitable, with an operating margin of -4.8% against -321.6%.
Where the money goes: TNXP and AYTU
Tonix Pharmaceuticals Holding (TNXP) · Q3 2026
Tonix Pharmaceuticals Holding, Q3 2026: revenue $17.2M (+424% year over year), operating margin -321.6%, net loss $53.3M, operating cash flow −$41.1M. The chart follows the revenue to costs, profit and cash.
Aytu Biopharma (AYTU) · Q4 FY26
Aytu Biopharma, Q4 FY26: revenue $16.1M (+6% year over year), operating margin -4.8%, net loss $15K, operating cash flow $4.4M. The chart follows the revenue to costs, profit and cash.
| Tonix Pharmaceuticals Holding (TNXP) | Aytu Biopharma (AYTU) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q4 FY26 |
| Revenue | $17.2M | $16.1M |
| Revenue growth, Y/Y | +424% | +6% |
| Operating margin | -321.6% | -4.8% |
| Net earnings | −$53.3M | −$15K |
| Net margin | -309.4% | -0.1% |
| Operating cash flow | −$41.1M | $4.4M |
| Free cash flow | — | $4.4M |
Where the revenue comes from
Tonix Pharmaceuticals Holding
- Tonmya: $15.0M (87%)
- Zembrace Symtouch: $1.5M (9%)
- Tosymra: $689K (4%)
Questions
Which is bigger, Tonix Pharmaceuticals Holding or Aytu Biopharma?
Tonix Pharmaceuticals Holding is the larger company: $17.2M of revenue in its latest quarter (Q3 2026) against $16.1M for Aytu Biopharma (Q4 FY26).
Is Tonix Pharmaceuticals Holding or Aytu Biopharma growing faster?
Tonix Pharmaceuticals Holding is growing faster (+424% against +6% a year earlier).
Which is more profitable, Tonix Pharmaceuticals Holding or Aytu Biopharma?
Aytu Biopharma is more profitable, with an operating margin of -4.8% against -321.6%.
More: Tonix Pharmaceuticals Holding earnings · how Tonix Pharmaceuticals Holding makes money · Aytu Biopharma earnings · how Aytu Biopharma makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 9, 2026; 10-K filed Sep 22, 2026). Fiscal quarters can end on different dates. Not investment advice.